HeartBeam has secured US Food and Drug Administration (FDA) clearance for its 12-lead electrocardiogram (ECG) synthesis ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.

Pulse Biosciences has partnered with The University of Texas MD Anderson Cancer Centre to investigate the use of the nPulse ...

Europe currently has a strong opportunity to become a key global player in agentic artificial intelligence (agentic AI) and ...

Medline has filed for an initial public offering (IPO) seeking to raise up to $5.37bn, a figure that would leave the medical ...

Aquapass has secured marketing approval in Israel for the AQUAPASS System, intended for patients experiencing fluid overload.

Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US FDA for its breast cancer ...

Singapore Health Sciences Authority (HSA) has granted approval for Respiree’s 1Bio AI-Acute toolbox, classifying it as a ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

The US Food and Drug Administration (FDA) has launched Technology-Enabled Meaningful Patient Outcomes (TEMPO), a pilot that ...

Conmed is exiting its gastroenterology business, reflecting the company’s aim to sharpen its focus on higher growth margin business lines as part of a broader portfolio optimisation strategy.